BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Evans H, Balasegaram S, Douthwaite S, Hunter L, Kulasegaram R, Wong T, Querol-Rubiera A, Nebbia G. An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department. PLoS One 2018;13:e0198520. [PMID: 30044779 DOI: 10.1371/journal.pone.0198520] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Jie W, Ling J, Yuanshuai H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal 2021;35:e23755. [PMID: 33788295 DOI: 10.1002/jcla.23755] [Reference Citation Analysis]
2 Buchanan R, Cooper K, Grellier L, Khakoo SI, Parkes J. The testing of people with any risk factor for hepatitis C in community pharmacies is cost-effective. J Viral Hepat 2020;27:36-44. [PMID: 31520434 DOI: 10.1111/jvh.13207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Martel-Laferriere V, Baril JG, Alarie I, Leblanc J, Côté J, Jourdenais E, Horth D, Lambert G, Tremblay C. Opt-out universal HCV and HIV screening in a Canadian emergency room: a cross-sectional study. BMJ Open 2022;12:e048748. [PMID: 35042704 DOI: 10.1136/bmjopen-2021-048748] [Reference Citation Analysis]
4 Bundle N, Balasegaram S, Parry S, Ullah S, Harris RJ, Ahmad K, Foster GR, Tong CY, Orkin C. Seroprevalence and demographic factors associated with hepatitis B, hepatitis C and HIV infection from a hospital emergency department testing programme, London, United Kingdom, 2015 to 2016. Euro Surveill 2019;24. [PMID: 31290390 DOI: 10.2807/1560-7917.ES.2019.24.27.1800377] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
5 Ford JS, Marianelli LG, Frassone N, Debes JD. Hepatitis B screening in an argentine ED: Increasing vaccination in a resource-limited setting. Am J Emerg Med 2020;38:296-9. [PMID: 31353159 DOI: 10.1016/j.ajem.2019.158354] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Williams J, Vickerman P, Douthwaite S, Nebbia G, Hunter L, Wong T, Ruf M, Miners A. An Economic Evaluation of the Cost-Effectiveness of Opt-Out Hepatitis B and Hepatitis C Testing in an Emergency Department Setting in the United Kingdom. Value Health 2020;23:1003-11. [PMID: 32828211 DOI: 10.1016/j.jval.2020.03.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Byrne C, Robinson E, Rae N, Dillon JF. Toward microelimination of hepatitis C and HIV coinfection in NHS Tayside, Scotland: Real-world outcomes. Health Sci Rep. 2020;3:e191. [PMID: 33033752 DOI: 10.1002/hsr2.191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
8 Marcellusi A, Mennini FS, Ruf M, Galli C, Aghemo A, Brunetto MR, Babudieri S, Craxi A, Andreoni M, Kondili LA. Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation. Liver Int 2021. [PMID: 34582627 DOI: 10.1111/liv.15070] [Reference Citation Analysis]
9 Long T, Rowland A, Cotterill S, Woby S, Heal C, Garratt N, Brown S, Roland D. Opt-out Consent in Children's Emergency Medicine Research. Compr Child Adolesc Nurs 2020;:1-12. [PMID: 32936676 DOI: 10.1080/24694193.2020.1812766] [Reference Citation Analysis]
10 Mendlowitz AB, Naimark D, Wong WWL, Capraru C, Feld JJ, Isaranuwatchai W, Krahn M. The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluation. Liver Int. 2020;40:1282-1291. [PMID: 32267604 DOI: 10.1111/liv.14458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]